ArticleJournal of family medicine and primary care2025
Management of prediabetes and class III obesity in a 42-year-old male through One-Meal-a-Day.
Article in Journal of family medicine and primary care, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A 42-year-old man with class III obesity (body mass index [BMI] ≈40 kg/m²), prediabetes (glycated hemoglobin (HbA1c) 6.2%), and stage-2 hypertension (≈150/95 mmHg) underwent a supervised lifestyle intervention. His diet was modified to a one-meal-a-day (OMAD) regimen emphasizing Dietary Approaches to Stop Hypertension (DASH)-style nutrition, coupled with regular exercise (swimming and walking). After three months, he lost ~10% of his body weight, with notable improvements in BMI, HbA1c, alanine aminotransferase (ALT), and blood pressure. Despite these gains, low-density lipoprotein (LDL) cholesterol paradoxically rose. We review recent literature on OMAD/intermittent fasting (IF), the effects of exercise on metabolism, and lifestyle management of obesity and prediabetes. The case outcomes largely align with evidence that IF plus exercise aids weight loss and glycemic control, but we discuss potential lipid risks and underscore the need for medical oversight. This case highlights a novel, patient-adapted regimen of OMAD/DASH and exercise, illustrating how intensive behavioral interventions can improve metabolic health while requiring careful monitoring of lipid changes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.